Mutations of the Smad4 gene in acute myelogeneous leukemia and their functional implications in leukemogenesis
暂无分享,去创建一个
Shigeru Chiba | Seishi Ogawa | S. Ogawa | M. Kurokawa | K. Mitani | K. Izutsu | H. Hirai | S. Chiba | K. Maki | Akira Hangaishi | Mineo Kurokawa | Hisamaru Hirai | A. Hangaishi | Yoichi Imai | Kazuhiro Maki | Kinuko Mitani | Y. Imai | Koji Izutsu
[1] R. Derynck,et al. Regulation of Smad signalling by protein associations and signalling crosstalk. , 1999, Trends in cell biology.
[2] S. Ogawa,et al. Inactivation of multiple tumor-suppressor genes involved in negative regulation of the cell cycle, MTS1/p16INK4A/CDKN2, MTS2/p15INK4B, p53, and Rb genes in primary lymphoid malignancies. , 1996, Blood.
[3] K. Tanaka,et al. Homozygous loss of the cyclin-dependent kinase 4-inhibitor (p16) gene in human leukemias. , 1994, Blood.
[4] Y. Yazaki,et al. Dual functions of the AML1/Evi-1 chimeric protein in the mechanism of leukemogenesis in t(3;21) leukemias , 1995, Molecular and cellular biology.
[5] H. Gralnick,et al. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML‐MO) , 1991, British journal of haematology.
[6] Kohei Miyazono,et al. TGF-β signalling from cell membrane to nucleus through SMAD proteins , 1997, Nature.
[7] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[8] Jeffrey L. Wrana,et al. Mechanism of activation of the TGF-β receptor , 1994, Nature.
[9] P. Dijke,et al. DPC4 (SMAD4) mediates transforming growth factor-β1 (TGF-β1) induced growth inhibition and transcriptional response in breast tumour cells , 1997, Oncogene.
[10] J. Massagué,et al. Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes. , 1997, Genes & development.
[11] H. Hirai,et al. An acute myeloid leukemia gene, AML1, regulates hemopoietic myeloid cell differentiation and transcriptional activation antagonistically by two alternative spliced forms. , 1995, The EMBO journal.
[12] K. Kinzler,et al. Targeted deletion of Smad4 shows it is required for transforming growth factor beta and activin signaling in colorectal cancer cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[13] K. Irie,et al. The oncoprotein Evi-1 represses TGF-β signalling by inhibiting Smad3 , 1998, Nature.
[14] M. Taniwaki,et al. Rare Alteration of Genomic Structure or Expression of the DPC4 Gene in Myelogenous Leukemias , 1998, Acta Haematologica.
[15] T. Musci,et al. The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function , 1997, Current Biology.
[16] R. Derynck,et al. The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-beta-induced transcriptional activation. , 1998, Genes & development.
[17] C. Heldin,et al. Identification and Functional Characterization of a Smad Binding Element (SBE) in the JunB Promoter That Acts as a Transforming Growth Factor-β, Activin, and Bone Morphogenetic Protein-inducible Enhancer* , 1998, The Journal of Biological Chemistry.
[18] H. Lodish,et al. Synergistic cooperation of TFE3 and smad proteins in TGF-beta-induced transcription of the plasminogen activator inhibitor-1 gene. , 1998, Genes & development.
[19] R. Derynck,et al. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription , 1998, Nature.
[20] K. Tanaka,et al. TLE, the human homolog of groucho, interacts with AML1 and acts as a repressor of AML1-induced transactivation. , 1998, Biochemical and biophysical research communications.
[21] A. Bassols,et al. Two forms of transforming growth factor-β distinguished by multipotential haematopoietic progenitor cells , 1987, Nature.
[22] J. Massagué,et al. Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways , 1996, Nature.
[23] R. Derynck,et al. Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4 , 1997, Molecular and cellular biology.
[24] W. Wang,et al. Cooperative Binding of Smad Proteins to Two Adjacent DNA Elements in the Plasminogen Activator Inhibitor-1 Promoter Mediates Transforming Growth Factor β-induced Smad-dependent Transcriptional Activation* , 1999, The Journal of Biological Chemistry.
[25] S. Kern,et al. Dpc4 transcriptional activation and dysfunction in cancer cells. , 1998, Cancer research.
[26] Denis Vivien,et al. Direct binding of Smad3 and Smad4 to critical TGFβ‐inducible elements in the promoter of human plasminogen activator inhibitor‐type 1 gene , 1998, The EMBO journal.
[27] J. Massagué. TGF-beta signal transduction. , 1998, Annual review of biochemistry.
[28] G. Gaedicke,et al. Monocytoid leukemia cell line CTV-1: morphological, immunological and isoenzymatic characteristics. , 1986, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
[29] Yigong Shi,et al. A structural basis for mutational inactivation of the tumour suppressor Smad4 , 1997, Nature.
[30] Scott E. Kern,et al. DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1 , 1996, Science.
[31] T. Takeuchi,et al. Processing of a fusion protein by endoprotease in COS-1 cells for secretion of mature peptide by using a chimeric expression vector. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[32] R. Derynck,et al. Receptor-associated Mad homologues synergize as effectors of the TGF-β response , 1996, Nature.
[33] Takeshi Imamura,et al. Smad proteins exist as monomers in vivo and undergo homo‐ and hetero‐oligomerization upon activation by serine/threonine kinase receptors , 1998, The EMBO journal.